VRTX — Vertex Pharmaceuticals
Health Care|Biotechnology
2 Articles
VRTXEarningspositive
Vertex Pharma Reports Record $15.32 EPS for 2025, Beating Estimates by 18%
Vertex Pharmaceuticals delivered exceptional Q4 2025 results with full-year EPS of $15.32 and net income of $3.95 billion, driven by strong cystic fibrosis franchise growth.
3 min read
VRTXInsider Tradingneutral
11 Vertex Execs Sell $18M in Stock Following RSU Vesting
Vertex Pharmaceuticals insiders sold $18.1 million worth of stock between Feb 16-23, with all transactions tied to restricted stock vesting and tax obligations.
3 min read